| Literature DB >> 31762342 |
Sara Birch1,2, Maiken Stilling2,3,4, Inger Mechlenburg2,4,5, Torben Baek Hansen2,3.
Abstract
Background and purpose - Pain catastrophizing contributes to acute and long-term pain after total knee arthroplasty (TKA) but currently there are only limited treatment options. This study investigates the effectiveness of patient education in pain coping among patients with moderate to high pain catastrophizing score before TKA. Secondary outcomes were physical function, quality of life, self-efficacy, and pain catastrophizing.Patients and methods - The study was a parallel-group randomized controlled trial including patients with moderate to high levels of pain catastrophizing. 60 patients were recruited from December 2015 to June 2018. The mean age of the patients was 66 (47-82) years and 40 were women. The patients were randomized to either cognitive-behavioral therapy (CBT) based pain education or usual care. The primary outcome measure was pain under activity measured with the Visual Analog Scale (VAS). All outcomes were measured preoperatively, at 3 months, and at 1 year after surgery.Results - We found no difference in the primary outcome measure, VAS during activity, between the 2 groups but both groups had large reductions over time. The CBT-based pain education group reduced their VAS score by 37 mm (95% CI 27-46) and the control group by 40 mm (CI 31-49). We found no statistically significantly differences between the 2 groups in any of the secondary outcomes.Interpretation - Future research is warranted to identify predictors of persistent pain and interventions for the approximately 20% of patients with persisting pain after a TKA.Entities:
Mesh:
Year: 2019 PMID: 31762342 PMCID: PMC7006640 DOI: 10.1080/17453674.2019.1694312
Source DB: PubMed Journal: Acta Orthop ISSN: 1745-3674 Impact factor: 3.717
Figure 1.CONSORT flowchart of the trial. PCS = Pain Catastrophizing Scale
Baseline demographics and characteristics. Values are mean (SD) unless otherwise specified
| Pain education | Usual care | |
|---|---|---|
| n = 31 | n = 29 | |
| Women, n | 22 | 18 |
| Age | 66 (9) | 66 (10) |
| BMI | 33 (5) | 33 (7) |
| Civil status, n | ||
| Cohabiting | 25 | 19 |
| Living alone | 6 | 10 |
| Daily smoker, n | 3 | 4 |
| Alcohol | 5 | 2 |
| Educational level, n | ||
| No education | 10 | 10 |
| < 3 years | 8 | 4 |
| ≥ 3 years | 8 | 7 |
| Other | 5 | 8 |
| Work status, n | ||
| Employed | 6 | 8 |
| Sick leave | 3 | 2 |
| Retired | 22 | 19 |
| Pain medication in the past week | ||
| Paracetamol, n | 27 | 26 |
| Ibuprofen, n | 16 | 13 |
| Morphine or opioids, n | 10 | 2 |
| Amount of opioids/day, mg | 33 (32) | 10 (0) |
| Postoperative, n | ||
| Operated in knee or hip within 1 year | 3 | 3 |
| Complications within 30 days | 1 | 1 |
| Rehabilitation | 16 | 14 |
| Primary outcome | ||
| VAS during activity | 48 (18) | 49 (21) |
| Secondary outcome | ||
| VAS during rest | 19 (14) | 25 (17) |
| OKS | 21 (7) | 22 (6) |
| KOOS Pain (n = 58) | 40 (12) | 37 (17) |
| EQ5D (n = 55), median (range) | 0.66 | 0.72 |
| (0.16–0.83) | (–0.14 to 0.83) | |
| PSEQ | 33 (10) | 34 (8) |
| PCS, median (range) | 28 (23–48) | 29 (23–52) |
| 6-minute walk test | 387 (106) | 334 (103) |
| STS | 10.3 (3.2) | 9.2 (2.8) |
Consumption above recommendations (more than 1 unit of alcohol per day for women and 2 for men).
Infection or brisement forcй.
Community-based after the operation.
VAS, Visual Analog Scale; OKS, Oxford Knee Score;
KOOS, Knee Injury and Osteoarthritis Outcome Score;
EQ5D, EuroQol-5D; PSEQ, Pain Self-Efficacy Questionnaire;
PCS, Pain Catastrophizing Scale; STS, Sit-to-stand in 30 seconds.
Primary and secondary outcomes at baseline, 3 and 12 months. The estimates are given as mean values with 95% CI from the linear mixed effect model
| Pain education | Usual care | |||
|---|---|---|---|---|
| n = 31 | n | n = 29 | n | |
| Primary outcome | ||||
| VAS during activity | ||||
| Baseline | 48 (41–55) | 31 | 49 (42–57) | 29 |
| 3 months | 22 (14–30) | 24 | 15 (8–23) | 24 |
| 12 months | 12 (5–18) | 24 | 9 (3–15) | 26 |
| Secondary outcome | ||||
| VAS during rest | ||||
| Baseline | 19 (13–24) | 31 | 25 (19–30) | 29 |
| 3 months | 11 (6–16) | 24 | 7 (3–12) | 25 |
| 12 months | 7 (1–12) | 24 | 6 (1–12) | 26 |
| Oxford Knee Score | ||||
| Baseline | 21 (19–23) | 31 | 22 (20–24) | 29 |
| 3 months | 28 (25–32) | 24 | 31 (27–34) | 25 |
| 12 months | 33 (29–37) | 24 | 37 (33–41) | 24 |
| KOOS pain | ||||
| Baseline | 40 (35–45) | 31 | 37 (32–43) | 27 |
| 3 months | 64 (57–72) | 25 | 69 (61–77) | 22 |
| 12 months | 75 (67–82) | 24 | 83 (75– 90) | 23 |
| EQ-5D | ||||
| Baseline | 0.58 (0.52–0.66) | 29 | 0.62 (0.54–0.70) | 26 |
| 3 months | 0.72 (0.65–0.79) | 24 | 0.82 (0.78–0.87) | 23 |
| 12 months | 0.78 (0.70–0.86) | 24 | 0.86 (0.81–0.91) | 24 |
| PSEQ | ||||
| Baseline | 33 (30–36) | 31 | 34 (31–38) | 29 |
| 3 months | 43 (38–47) | 25 | 47 (43–52) | 25 |
| 12 months | 49 (44–53) | 23 | 52 (48–57) | 25 |
| PCS | ||||
| Baseline | 30 (28–32) | 31 | 31 (29–33) | 29 |
| 3 months | 13 (9–17) | 25 | 11 (7–15) | 25 |
| 12 months | 11 (7–16) | 23 | 9 (5–14) | 25 |
| 6-minute walk test | ||||
| Baseline | 387 (350–424) | 31 | 334 (296–372) | 29 |
| 3 months | 405 (372–438) | 24 | 375 (342–408) | 25 |
| 12 months | 441 (402–480) | 24 | 406 (367–446) | 26 |
| Sit to stand | ||||
| Baseline | 10 (9–11) | 31 | 9 (8–10) | 29 |
| 3 months | 11 (9–13) | 24 | 10 (8–11) | 25 |
| 12 months | 12 (11–14) | 24 | 11 (10–13) | 26 |
For abbreviations, see Table 1.
p = 0.01
Figure 2.Pain during activity for the two groups over the study period. Mean Visual Analog Scale (VAS) scores with 95% CI in error bars for the pain education group (green dot) and the usual care group (red dot).